Skip to main navigation
Skip to search
Skip to main content
Prinses Máxima Centrum Home
Nederlands
English
Search content at Prinses Máxima Centrum
Home
Profiles
Research Groups
Equipment
Research output
Prizes
Activities
Press/Media
Oligodendroglioma: pathology, molecular mechanisms and markers
Pieter Wesseling
, Martin van den Bent
, Arie Perry
Research output
:
Contribution to journal
›
Review article
›
peer-review
193
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Oligodendroglioma: pathology, molecular mechanisms and markers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Molecular Mechanism
100%
Molecular Markers
100%
Oligodendroglioma
100%
Codeletion
42%
Molecular Diagnostics
28%
Isocitrate Dehydrogenase 1 (IDH1)
28%
Oligoastrocytoma
28%
1p/19q Codeletion
28%
Clinical Trials
14%
Long Follow-up
14%
Promoter Methylation
14%
Diffuse Glioma
14%
Glioma
14%
Prognostic Information
14%
Gene mutation
14%
Molecular Information
14%
Tailored Treatment
14%
Chromosome 1p
14%
Histological Criteria
14%
Balanced Translocation
14%
Molecular Signature
14%
Prognostic Role
14%
Molecular Aberrations
14%
Predictive Role
14%
Cut-off Level
14%
FUBP1
14%
Smart Integration
14%
Morphological Data
14%
Predictive Information
14%
Morphological Diagnosis
14%
MGMT Gene
14%
Pediatric Oligodendroglioma
14%
Diagnostic Role
14%
Biochemistry, Genetics and Molecular Biology
Morphology
100%
Clinical Trial
50%
Gene Mutation
50%
Promoter Region
50%
Chromosome 1p
50%
Chromosome 19q
50%
IDH1
50%
IDH2
50%
Medicine and Dentistry
Oligodendroglioma
100%
Molecular Pathology
100%
Diagnosis
25%
Morphology
25%
Ganglioglioma
25%
Oligoastrocytoma
25%
Pediatrics
12%
Clinical Trial
12%
Biological Marker
12%
Gene Mutation
12%
Molecular Diagnosis
12%
Molecular Diagnostics
12%
Histopathology
12%
Promoter Region
12%
Chromosome 1p
12%
Chromosome 19q
12%
Immunology and Microbiology
Morphology
100%
Promoter Region
50%
Gene Mutation
50%
Chromosome 19q
50%
Chromosome 1p
50%
Neuroscience
Oligodendroglioma
100%
Promoter Region
12%
Gene Mutation
12%
Chromosome 19q
12%
Chromosome 1p
12%
IDH2
12%
Histopathology
12%